CARCINOMA, HEPATOCELLULAR
Clinical trials for CARCINOMA, HEPATOCELLULAR explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, HEPATOCELLULAR trials appear
Sign up with your email to follow new studies for CARCINOMA, HEPATOCELLULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack aims to stop liver Cancer's return
Disease control Not yet recruitingThis study is testing a new combination treatment to prevent liver cancer from returning after surgery. It is for patients whose cancer has a specific high-risk feature called 'tumor budding.' Researchers will give patients two drugs: one to break down tissue barriers around the …
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE4 • Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New blood test could spot liver cancer sooner
Diagnosis Not yet recruitingThis study aims to see if a new blood test score, called GAAD, can help doctors find liver cancer earlier in people at high risk. It will enroll 2,100 adults with chronic liver disease or cirrhosis. Participants will get standard ultrasound checks plus the GAAD score test every s…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: NA • Sponsor: Siriraj Hospital • Aim: Diagnosis
Last updated Mar 31, 2026 12:12 UTC